Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FATI-01
PACTR201205000384379Phase 2Completed
- Sponsor
- LMU Klinikum
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2 trial of fozivudine tidoxil, lamivudine, efavirenz and zidovudine in Human immunodeficiency virus infection type 1, sponsored by LMU Klinikum. Started Aug 2012; status: completed.
02
Drugs
fozivudine tidoxillamivudineefavirenzzidovudine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on PACTR201205000384379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201205000384379.